4.6 Article

Associations between DNA methylation and BMI vary by metabolic health status: a potential link to disparate cardiovascular outcomes

Journal

CLINICAL EPIGENETICS
Volume 13, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13148-021-01194-3

Keywords

DNA methylation; Metabolically healthy; Obesity; Epigenetics

Funding

  1. National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C]
  2. National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]
  3. NHLBI
  4. Keck Molecular Genomics Core Facility [HHSN268201600034I]
  5. TOPMed Informatics Research Center [3R01HL-117626-02S1, HHSN268201800002I]
  6. TOPMed Data Coordinating Center [R01HL-120393, U01HL-120393, HHSN268201800001I]
  7. Nalini and Ravi Saligram Scholarship
  8. [5RC2HL102419]
  9. [R01NS087541]

Ask authors/readers for more resources

This study identified differential associations between DNA methylation and BMI based on metabolic health status at 22 CpG sites, with one site validated and three sites predictive of incident coronary heart disease (CHD). These findings suggest a potential role for inflammation in the relationship between DNA methylation and BMI-related metabolic health.
Background Body mass index (BMI), a well-known risk factor for poor cardiovascular outcomes, is associated with differential DNA methylation (DNAm). Similarly, metabolic health has also been associated with changes in DNAm. It is unclear how overall metabolic health outside of BMI may modify the relationship between BMI and methylation profiles, and what consequences this may have on downstream cardiovascular disease. The purpose of this study was to identify cytosine-phosphate-guanine (CpG) sites at which the association between BMI and DNAm could be modified by overall metabolic health. Results The discovery study population was derived from three Women's Health Initiative (WHI) ancillary studies (n = 3977) and two Atherosclerosis Risk in Communities (ARIC) ancillary studies (n = 3520). Findings were validated in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort (n = 1200). Generalized linear models regressed methylation beta values on the interaction between BMI and metabolic health Z score (BMI x MHZ) adjusted for BMI, MHZ, cell composition, chip number and location, study characteristics, top three ancestry principal components, smoking, age, ethnicity (WHI), and sex (ARIC). Among the 429,566 sites examined, differential associations between BMI x MHZ and DNAm were identified at 22 CpG sites (FDR q < 0.05), with one site replicated in MESA (cg18989722, in the TRAPPC9 gene). Three of the 22 sites were associated with incident coronary heart disease (CHD) in WHI. For each 0.01 unit increase in DNAm beta value, the risk of incident CHD increased by 9% in one site and decreased by 6-10% in two sites over 25 years. Conclusions Differential associations between DNAm and BMI by MHZ were identified at 22 sites, one of which was validated (cg18989722) and three of which were predictive of incident CHD. These sites are located in several genes related to NF-kappa-B signaling, suggesting a potential role for inflammation between DNA methylation and BMI-associated metabolic health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available